Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Chong Wu Image

      Chong Wu, PhD

      Department of Biostatistics, Division of Discovery Science

      About Dr. Chong Wu

      I am an Associate Professor in the Department of Biostatistics and Affiliate Member in the Institute for Data Science in Oncology at The University of Texas MD Anderson. Before that, I was an Assistant Professor in the Department of Statistics at Florida State University. Prior to FSU, I was a biostatistics Ph.D. student at the University of Minnesota, co-advised by Profs. Weihua Guan and Wei Pan. I received my bachelor's degree in Applied Math from Huazhong University of Science and Technology in 2013.


      My research program focuses on developing pioneering statistical methodologies and computational tools to analyze complex, large-scale biomedical data, particularly in genomics and genetics. My expertise spans DNA foundation models, LLM, statistical genetics (GWAS, TWAS, multi-omics integration, PRS), causal inference (Mendelian randomization, potential outcome frameworks), machine learning (clustering, prediction), and high-dimensional statistical inference. A major current focus is leveraging AI for scientific discovery, including developing foundational models for genetics, predicting cancer treatment outcomes using AI, exploring AI-driven drug discovery, and advancing AI applications in medicine more broadly. I am deeply committed to reproducible research, actively developing and maintaining open-source software (primarily R packages) to facilitate the adoption of our methods.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Affiliate, Institute for Data Science in Oncology (IDSO), The University of Texas MD Anderson Cancer Center, Houston, Texas

      Adjunct Assistant Professor, Department of Biostatistics and Data Science, UTHealth School of Public Health, Houston, Texas

      Research Interests

      Statistical genetics

      Causal inference

      Machine learning

      Risk prediction

      Education & Training

      Degree-Granting Education

      2018University of Minnesota, Minneapolis, Minnesota, US, Biostatistics, PhD
      2013Huazhong University of Science and Technology, Wuhan, CN, Math & Applied Math, BS

      Experience & Service

      Faculty Academic Appointments

      Adjunct Assistant Professor, Department of Statistics, Rice University, Houston, Texas, 2023 - 2025

      Assistant Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 2022 - 2026

      Adjunct Assistant Professor, Department of Statistics, Florida State University, Tallahassee, Florida, 2022 - 2025

      Assistant Professor, Department of Statistics, Florida State University, 2018 - 2022

      Intramural Institutional Committee Activities

      IRB Member, IRB 3, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Editorial Activities

      Associate Editor, BMC Genomics, 2024

      Guest Editor, Frontiers in Genetics, 2019

      Honors & Awards

      2020Dean’s Faculty Travel Award, Florida State University

      Professional Memberships

      American Statistical Association (ASA)

      2021 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2026. Towards end-to-end biomedical AI. Invited. DDC Research Forum. Houston, Texas, US.
      2. 2026. Towards end-to-end biomedical AI. Invited. Houston, Texas, US.
      3. 2025. Transformers and its applications. IDSO CollabHaus Presents. Houston, Texas, US.
      4. 2025. Leveraging AI and Large-Scale Clinical Data for Precision Treatment Response Prediction in Lung Cancer. Invited. Context Engine Meeting. Houston, Texas, US.
      5. 2023. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Invited. UTHealth Houston School of Public Health. Houston, Texas, US.
      6. 2020. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation: a multi-phased study of prostate cancer. Invited. Florida State University School of Medicine. Tallahassee, Florida, US.
      7. 2017. An adaptive test on high dimensional parameters in GLMs. Poster. MSI Research Exhibition. Minneapolis, Minnesota, US.

      Regional Presentations

      1. 2024. Large-scale imputation models for multi-ancestry proteome-wide association analysis. Invited. Division of Epidemiology Seminar, US.
      2. 2024. Large-scale imputation models for multi-ancestry proteome-wide association analysis. Invited. Mid South Computational Biology and Bioinformatics Society (MCBIOS) 2024, US.
      3. 2023. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Invited. Department of Epidemiology and Biostatistics Seminar, US.
      4. 2023. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Invited. Statistical Genetics/Genomics Journal Club, US.
      5. 2023. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Invited. Indiana University School of Medicine Seminar, US.
      6. 2023. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Invited. University of Hawaii Cancer Center Seminar, US.
      7. 2022. Accounting for winner’s curse and pleiotropy in two-sample Mendelian randomization. Invited. Causal Inference Working Group Journal Club, US.
      8. 2021. Accounting for winner’s curse and pleiotropy in two-sample Mendelian randomization. Invited. Biomedical Informatics & Genomics Center Seminar, US.
      9. 2021. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Invited. New Investigator in AD and AFAR Grantee Conference, US.
      10. 2020. A regularization-based adaptive test for high-dimensional generalized linear models. Invited. Department of Biostatistics Seminar, US.
      11. 2017. A gene-level adaptive association test for methylation data. Invited. Genetic Analysis Workshop (GAW) 20. San Diego, CA, US.

      National Presentations

      1. 2025. Benchmarking DNA Foundation Models for Genomic Sequence Classification. Invited. ENAR 2025 Spring Meeting. New Orleans, LA, US.
      2. 2024. Large-scale imputation models for multi-ancestry proteome-wide association analysis. Invited. Association of Chinese Americans in Cancer Research(ACACR) summer seminar, US.
      3. 2022. Accounting for winner’s curse and pleiotropy in two-sample Mendelian randomization. Invited. The ICSA 2022 Applied Statistics Symposium. Gainesville, FL, US.
      4. 2019. An adaptive test for high-dimensional generalized linear models with application to detect gene-environment interactions. Invited. ENAR 2019 Spring Meeting. Philadelphia, PA, US.
      5. 2018. Integration of methylation QTL and enhancer-target gene maps with schizophrenia GWAS summary results identifies novel genes. Conference. IGES 27th Annual Meeting. San Diego, California, US.
      6. 2017. An adaptive test on high dimensional parameters in GLMs. Invited. ENAR 2017 Spring Meeting. Washington, DC, US.
      7. 2016. An adaptive association test for microbiome data. Invited. Eastern North American Region (ENAR) 2016 Spring Meeting. Austin, TX, US.

      International Presentations

      1. 2025. Benchmarking DNA Foundation Models for Genomic Sequence Classification. Invited. 2025 Joint Statistical Meetings. Nashville, US.
      2. 2024. Large-scale imputation models for multi-ancestry proteome-wide association analysis. Invited. 2024 Joint Statistical Meetings. Portland, US.
      3. 2024. Large-scale imputation models for multi-ancestry proteome-wide association analysis. Invited. ICSA 2024 China Conference. Wuhan, CN.
      4. 2023. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Invited. The 12th International Chinese Statistical Association (ICSA) International Conference. Hong Kong, CN.
      5. 2023. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Invited. 2023 International Chinese Statistical Association (ICSA) Applied Statistics Symposium. Ann Arbor, US.
      6. 2021. Accounting for winner’s curse and pleiotropy in two-sample Mendelian randomization. Invited. Department of Statistics Seminar, US.
      7. 2021. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation: a multi-phased study of prostate cancer. Conference. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation: a multi-phased study of prostate cancer, US.
      8. 2020. A regularization-based adaptive test for high-dimensional generalized linear models. Invited. School of Statistics and Management Seminar, US.
      9. 2020. A gene-level methylome-wide association analysis identifies novel Alzheimer’s disease genes. Poster. ASHG 2020 Annual Meeting, US.
      10. 2020. A powerful fine-mapping method for transcriptome-wide association studies. Invited. 2020 Joint Statistical Meetings, US.
      11. 2019. Multi-trait genome-wide analyses of the brain imaging phenotypes in UK Biobank. Conference. ASHG 2019 Annual Meeting. Houston, US.
      12. 2019. Complex disease risk prediction via a deep learning method. Invited. 2019 Joint Statistical Meetings. Denver, US.
      13. 2017. Integrating eQTL data with GWAS summary statistics in pathway-based analysis. Conference. ASHG 2017 Annual Meeting. Orlando, US.
      14. 2017. An adaptive test on high dimensional parameters in GLMs. Invited. 2017 Joint Statistical Meetings. Baltimore, US.
      15. 2016. Iterative PCA in epigenome-wide association studies. Poster. American Society of Human Genetics (ASHG) 2016 Annual Meeting. Vancouver, CA.
      16. 2016. An adaptive association test for microbiome data. Invited. 2016 Joint Statistical Meetings (JSM). Chicago, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Xie Z, Zhang W, Wang J, Wu C. Winner’s Curse Free Robust Mendelian Randomization with Summary Data. Journal of the American Statistical Association, 2026. e-Pub 2026.
      2. Zhang Y, Xie F, Yang S, Wu C. Meta-Router: Bridging gold-standard and preference-based evaluations in large language model routing. ICLR 2026. e-Pub 2026.
      3. Montalban-Bravo G, Wu C, Rodriguez-Sevilla JJ, Wei Y, Chien KS, Bouligny I, Kanagal-Shamanna R, Li Z, Natu A, Gurney M, Bazinet A, Hammond D, Bataller A, Borthakur G, Short NJ, DiNardo CD, Kadia TM, Ravandi F, Daver N, Pemmaraju N, Jabbour E, Issa GC, Wang SA, Patel KP, Tang G, Medeiros L, Lasho TL, Finke CM, Al-Kali A, Csizmar CM, Alkhateeb H, Gangat N, Mangaonkar AA, Roman-Bravo D, Arenillas L, Tefferi A, Kantarjian HM, Garcia-Manero G, Calvo X, Patnaik MM, Loghavi S. Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia. Blood Cancer Discovery, 2026. e-Pub 2026. PMID: 41587375.
      4. Li Q, Song Q, Chen Z, Choi J, Moreno V, Ping J, Wen W, Li C, Shu X, Yan J, Shu X, Cai Q, Long J, Huyghe JR, Pai R, Gruber SB, Yang Y, Casey G, Wang X, Toriola AT, Li L, Singh B, Lau KS, Zhou L, Zhang Z, Wu C, Peters U, Zheng W, Long Q, Yin Z, Guo X. Large-scale integration of omics and electronic health records to identify potential risk protein biomarkers and therapeutic drugs for cancer prevention. The American Journal of Human Genetics 113(1), 2026. e-Pub 2026.
      5. Zhong H, Zhu J, Liu S, Wu C, Wang L, Whelton SP, Marshall CH, Blaha MJ, Durda P, Guo X, Johnson CW, Lin HJ, Taylor KD, Tracy RP, Yarden RI, Manichaikul AW, Rich SS, Rotter JI, Deo R, Dubin RF, Ganz P, Wu L. Proteome-wide association study of prostate cancer risk across populations. Nature Communications, 2025. e-Pub 2025. PMID: 41353205.
      6. Feng H, Wu L, Zhao B, Huff C, Zhang J, Wu J, Lin L, Wei P, Wu C. Benchmarking DNA foundation models for genomic and genetic tasks. Nature Communications, 2025. e-Pub 2025. PMID: 41315262.
      7. Anand, Vivek, Oderinde B, Siddiqui M, Tyagi A, Borgman J, Wu C, Andreeff M, Battula LV. Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer. NPJ Breast Cancer 11(1), 2025. e-Pub 2025. PMID: 41188249.
      8. Li S, Wu C, Zhang Z, Xiao M, Murad MH, Lin L. Lifecycles of Cochrane Systematic Reviews (2003–2024): A Bibliographic Study. Cochrane Evidence Synthesis and Methods 3(5):e70043, 2025. e-Pub 2025. PMID: 40838186.
      9. Zhong H, Zhu J, Liu S, Zhou D, Long Q, Wu C, Zhao B, Cheng C, Yang Y, Wu Q, Wu Y, Li C, Wang Z, Wu J, Guo X, Zhi D, Deng Y, Wu L. Linking DNA methylation in brain regions to Alzheimer’s disease risk: a Mendelian randomization study. Human Molecular Genetics, 2025. e-Pub 2025. PMID: 40267236.
      10. Sun Y, Zhu J, Zhong H, Zhang Z, Wang F, Nakamura A, Liu Y, Liu J, Yu J, Zeng G, Lin X, Zhou D, Wu C, Wang L, Deng Y, Wu L. Transcriptome‐wide association study identified novel blood tissue gene biomarkers for prostate cancer risk. The Prostate 85:567-579, 2025. e-Pub 2025. PMID: 39878408.
      11. Gu C, Ghasemi SM, Cai Y, Fahrmann JF, Long JP, Katayama H, Wu C, Vykoukal J, Dennison JB, Hanash S, Do KA, Irajizad E. Grape-Pi: Graph-based neural networks for enhanced protein identification in proteomics pipelines. Bioinformatics Advances 5(1):vbaf095, 2025. e-Pub 2025. PMID: 40406669.
      12. Wang Z, Xing X, Mun EY, Wu C, Lin L. The role of double‐zero‐event studies in evidence synthesis: Evaluating robustness using the fragility index. Journal of Evaluation in Clinical Practice 31(1):e14301, 2025. e-Pub 2025. PMID: 39780615.
      13. Liu S, Zhu J, Green D, Zhong H, Long Q, Wu C, Wang L, Deng Y, Wu L. Integrating multi-omics data to uncover prostate tissue DNA methylation biomarkers and target genes for prostate cancer risk. Molecular Carcinogenesis 64(1):83-90, 2025. e-Pub 2025. PMID: 39400371.
      14. King A, Wu C. Integrative multi-omics approach for improving causal gene identification. Genetic Epidemiology 49(1):e22601, 2025. e-Pub 2025. PMID: 39444114.
      15. Yu J, Zhu J, Zhong H, Zhang Z, Liu J, Lin X, Zeng G, Zhang M, Wu C, Deng Y, Sun Y, Wu L. Age-related hearing impairment: Genome and blood methylome data integration reveals candidate epigenetic biomarkers. OMICS: A Journal of Integrative Biology 28(12):620-631, 2024. e-Pub 2024. PMID: 39585213.
      16. Liu S, Zhu J, Zhong H, Wu C, Xue H, Darst BF, Guo X, Durda P, Tracy RP, Liu Y, Johnson WC, Taylor KD, Manichaikul AW, Goodarzi MO, Gerszten RE, Clish CB, Chen YI, Highland H, Haiman CA, Gignoux CR, Lange L, Conti DV, Raffield LM, Wilkens L, Marchand LL, North KE, Young KL, Loos RJ, Buyske S, Matise T, Peters U, Kooperberg C, Reiner AP, Yu B, Boerwinkle E, Sun Q, Rooney MR, Echouffo-Tcheugui JB, Daviglus ML, Qi Q, Mancuso N, Li C, Deng Y, Manning A, Meigs JB, Rich SS, Rotter JI, Wu L. Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations. Diabetologia 67(12):2754-2770, 2024. e-Pub 2024. PMID: 39349773.
      17. Zhao C, Su KJ, Wu C, Cao X, Sha Q, Li W, Luo Z, Qing T, Qiu C, Zhao LJ, Liu A, Jiang L, Zhang X, Shen H, Zhou W, Deng HW. Multi-scale variational autoencoder for imputation of missing values in untargeted metabolomics using whole-genome sequencing data. Computers in Biology and Medicine 179, 2024. e-Pub 2024. PMID: 38955127.
      18. Liu Y, Meng XH, Wu C, Su KJ, Liu A, Tian Q, Zhao LJ, Qiu C, Luo Z, Gonzalez-Ramirez MI, Shen H, Xiao HM, Deng HW. Variability in performance of genetic-enhanced DXA-BMD prediction models across diverse ethnic and geographic populations: A risk prediction study. PLoS Medicine 21(8):e1004451, 2024. e-Pub 2024. PMID: 39213443.
      19. Lin W, Ji J, Su KJ, Qiu C, Tian Q, Zhao LJ, Luo Z, Wu C, Shen H, Deng HW. omicsMIC: a comprehensive benchmarking platform for robust comparison of imputation methods in mass spectrometry-based omics data. NAR Genomics and Bioinformatics 6(2):lqae071, 2024. e-Pub 2024. PMID: 38881578.
      20. Meng Z, Wang J, Lin L, Wu C. Sensitivity analysis with iterative outlier detection for systematic reviews and meta-analyses. Statistics in Medicine 43(8):1549-1563, 2024. e-Pub 2024. PMID: 38318993.
      21. Lyu Y, Wu C, Sun W, Li Z. Regional analysis to delineate intrasample heterogeneity with RegionalST. Bioinformatics 40(4), 2024. e-Pub 2024. PMID: 38579257.
      22. Melton HJ, Zhang Z, Wu C. SUMMIT-FA: a new resource for improved transcriptome imputation using functional annotations. Human Molecular Genetics 33(7):624-635, 2024. e-Pub 2024. PMID: 38129112.
      23. Zhu J, Liu S, Walker KA, Zhong H, Ghoneim DH, Zhang Z, Surendran P, Fahle S, Butterworth A, Alam MA, Deng HW, Wu C, Wu L. Associations between genetically predicted plasma protein levels and Alzheimer's disease risk: a study using genetic prediction models. Alzheimer's Research & Therapy 16(1):8, 2024. e-Pub 2024. PMID: 38212844.
      24. Zhu J, Wu K, Liu S, Masca A, Zhong H, Yang T, Ghoneim DH, Surendran P, Liu T, Yao Q, Liu T, Fahle S, Butterworth A, Alam MA, Vadgama JV, Deng Y, Deng HW, Wu C, Wu Y, Wu L. Proteome-wide association study and functional validation identify novel protein markers for pancreatic ductal adenocarcinoma. Gigascience 13, 2024. e-Pub 2024. PMID: 38608280.
      25. Melton HJ, Zhang Z, Deng HW, Wu L, Wu C. MIMOSA: a resource consisting of improved methylome prediction models increases power to identify DNA methylation-phenotype associations. Epigenetics 19(1), 2024. e-Pub 2024. PMID: 38963888.
      26. Sun Y, Zhu J, Yang Y, Zhang Z, Zhong H, Zeng G, Zhou D, Nowakowski RS, Long J, Wu C, Wu L. Identification of candidate DNA methylation biomarkers related to Alzheimer's disease risk by integrating genome and blood methylome data. Translational Psychiatry 13(1):387, 2023. e-Pub 2023. PMID: 38092781.
      27. Liu D, Bae YE, Zhu J, Zhang Z, Sun Y, Deng Y, Wu C, Wu L. Splicing transcriptome-wide association study to identify splicing events for pancreatic cancer risk. Carcinogenesis 44(10-11):741-747, 2023. e-Pub 2023. PMID: 37769343.
      28. Zhong H, Zhu J, Liu S, Ghoneim DH, Surendran P, Liu T, Fahle S, Butterworth A, Ashad Alam M, Deng HW, Yu H, Wu C, Wu L. Identification of blood protein biomarkers associated with prostate cancer risk using genetic prediction models: analysis of over 140,000 subjects. Human Molecular Genetics 32(22):3181-3193, 2023. e-Pub 2023. PMID: 37622920.
      29. Wei W, Petersen M, van der Laan MJ, Zheng Z, Wu C, Wang J. Efficient targeted learning of heterogeneous treatment effects for multiple subgroups. Biometrics 79(3):1934-1946, 2023. e-Pub 2023. PMID: 36416173.
      30. Sun Y, Bae YE, Zhu J, Zhang Z, Zhong H, Cheng C, Deng Y, Wu C, Wu L. A splicing transcriptome-wide association study identifies candidate altered splicing for prostate cancer risk. OMICS 27(8):372-380, 2023. e-Pub 2023. PMID: 37486714.
      31. Sun Y, Bae YE, Zhu J, Zhang Z, Zhong H, Yu J, Wu C, Wu L. A splicing transcriptome-wide association study identifies novel altered splicing for Alzheimer's disease susceptibility. Neurobiology of Disease 184:106209, 2023. e-Pub 2023. PMID: 37354922.
      32. Meng Z, Wu C, Lin L. The effect direction should be taken into account when assessing small-study effects. Journal of Evidence-Based Dental Practice 23(1):101830, 2023. e-Pub 2023. PMID: 36914304.
      33. Ma X, Wang J, Wu C. Breaking the winner's curse in Mendelian randomization. The Annals of Statistics 51(1):211-232, 2023. e-Pub 2023.
      34. Guo X, Wei W, Liu M, Cai T, Wu C, Wang J. Assessing the most vulnerable subgroup to Type II diabetes associated with statin usage: Evidence from electronic health record data. Journal of the American Statistical Association 118(543):1488-1499, 2023. e-Pub 2023. PMID: 38223220.
      35. King A, Wu L, Deng HW, Shen H, Wu C. Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease. BMC Medicine 20(1):385, 2022. e-Pub 2022. PMID: 36336692.
      36. Zhang Z, Bae YE, Bradley JR, Wu L, Wu C. SUMMIT: An integrative approach for better transcriptomic data imputation improves causal gene identification. Nature Communications 13(1):6336, 2022. e-Pub 2022. PMID: 36284135.
      37. Liu D, Zhu J, Zhou D, Nikas EG, Mitanis NT, Sun Y, Wu C, Mancuso N, Cox NJ, Wang L, Freedland SJ, Haiman CA, Gamazon ER, Nikas JB, Wu L. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk. International Journal of Cancer 150(1):80-90, 2022. e-Pub 2022. PMID: 34520569.
      38. Song M, Greenbaum J, Luttrell J, Zhou W, Wu C, Luo Z, Qiu C, Zhao LJ, Su KJ, Tian Q, Shen H, Hong H, Gong P, Shi X, Deng HW, Zhang C. An autoencoder-based deep learning method for genotype imputation. Frontiers in Artificial Intelligence 5:1028978, 2022. e-Pub 2022. PMID: 36406474.
      39. Sun Y, Zhou D, Rahman MR, Zhu J, Ghoneim D, Cox NJ, Beach TG, Wu C, Gamazon ER, Wu L. A transcriptome-wide association study identifies novel blood-based gene biomarker candidates for Alzheimer's disease risk. Human Molecular Genetics 31(2):289-299, 2021. e-Pub 2021. PMID: 34387340.
      40. Bae YE, Wu L, Wu C. InTACT: An adaptive and powerful framework for joint-tissue transcriptome-wide association studies. Genetic Epidemiology 45(8):848-859, 2021. e-Pub 2021. PMID: 34255882.
      41. Wu C, Zhu J, King A, Tong X, Lu Q, Park JY, Wang L, Gao G, Deng HW, Yang Y, Knudsen KE, Rebbeck TR, Long J, Zheng W, Pan W, Conti DV, Haiman CA, Wu L. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer. Cancer Communications 41(12):1387-1397, 2021. e-Pub 2021. PMID: 34520132.
      42. Yu G, Sun K, Xu C, Shi XH, Wu C, Xie T, Meng RQ, Meng XH, Wang KS, Xiao HM, Deng HW. Accurate recognition of colorectal cancer with semi-supervised deep learning on pathological images. Nature Communications 12(1):6311, 2021. e-Pub 2021. PMID: 34728629.
      43. Wu L, Zhu J, Liu D, Sun Y, Wu C. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity. Genetics in Medicine 23(11):2076-2086, 2021. e-Pub 2021. PMID: 34183789.
      44. Sun Y, Zhu J, Zhou D, Canchi S, Wu C, Cox NJ, Rissman RA, Gamazon ER, Wu L. A transcriptome-wide association study of Alzheimer's disease using prediction models of relevant tissues identifies novel candidate susceptibility genes. Genome Medicine 13(1):141, 2021. e-Pub 2021. PMID: 34470669.
      45. Wu C, Bradley J, Li Y, Wu L, Deng HW. A gene-level methylome-wide association analysis identifies novel Alzheimer's disease genes. Bioinformatics 37(14):1933-1940, 2021. e-Pub 2021. PMID: 33523132.
      46. Wang KS, Yu G, Xu C, Meng XH, Zhou J, Zheng C, Deng Z, Shang L, Liu R, Su S, Zhou X, Li Q, Li J, Wang J, Ma K, Qi J, Hu Z, Tang P, Deng J, Qiu X, Li BY, Shen WD, Quan RP, Yang JT, Huang LY, Xiao Y, Yang ZC, Li Z, Wang SC, Ren H, Liang C, Guo W, Li Y, Xiao H, Gu Y, Yun JP, Huang D, Song Z, Fan X, Chen L, Yan X, Li Z, Huang ZC, Huang J, Luttrell J, Zhang CY, Zhou W, Zhang K, Yi C, Wu C, Shen H, Wang YP, Xiao HM, Deng HW. Accurate diagnosis of colorectal cancer based on histopathology images using artificial intelligence. BMC Medicine 19(1):76, 2021. e-Pub 2021. PMID: 33752648.
      47. He Y, Xu G, Wu C, Pan W. Asymptotically independent U-statistics in high-dimensional testing. Annals of Statistics 49(1):154-181, 2021. e-Pub 2021. PMID: 34857975.
      48. Zhu J, Wu C, Wu L. Associations Between Genetically Predicted Protein Levels and COVID-19 Severity. Journal of Infectious Diseases 223(1):19-22, 2021. e-Pub 2021. PMID: 33083826.
      49. Wu C, Wu L, Wang J, Lin L, Li Y, Lu Q, Deng HW. Systematic identification of risk factors and drug repurposing options for Alzheimer's disease. Alzheimer's Dement 7(1):e12148, 2021. e-Pub 2021. PMID: 33718584.
      50. Liu D, Zhou D, Sun Y, Zhu J, Ghoneim D, Wu C, Yao Q, Gamazon ER, Cox NJ, Wu L. A transcriptome-wide association study identifies candidate susceptibility genes for pancreatic cancer risk. Cancer Research 80(20):4346-4354, 2020. e-Pub 2020. PMID: 32907841.
      51. Xue H, Wu C, Pan W. Leveraging existing GWAS summary data to improve power for a new GWAS. Genetic Epidemiology 44(7):717-732, 2020. e-Pub 2020. PMID: 32677173.
      52. Wu L, Yang Y, Guo X, Shu XO, Cai Q, Shu X, Li B, Tao R, Wu C, Nikas JB, Sun Y, Zhu J, Roobol MJ, Giles GG, Brenner H, John EM, Clements J, Grindedal EM, Park JY, Stanford JL, Kote-Jarai Z, Haiman CA, Eeles RA, Zheng W, Long J. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk. Nature Communications 11(1):3905, 2020. e-Pub 2020. PMID: 32764609.
      53. Wu C. Multi-trait genome-wide analyses of the brain imaging phenotypes in UK biobank. Genetics 215(4):947-958, 2020. e-Pub 2020. PMID: 32540950.
      54. Zhu J, Shu X, Guo X, Liu D, Bao J, Milne RL, Giles GG, Wu C, Du M, White E, Risch HA, Malats N, Duell EJ, Goodman PJ, Li D, Bracci P, Katzke V, Neale RE, Gallinger S, Van Den Eeden SK, Arslan AA, Canzian F, Kooperberg C, Beane Freeman LE, Scelo G, Visvanathan K, Haiman CA, Le Marchand L, Yu H, Petersen GM, Stolzenberg-Solomon R, Klein AP, Cai Q, Long J, Shu XO, Zheng W, Wu L. Associations between genetically predicted blood protein biomarkers and pancreatic cancer risk. Cancer Epidemiology Biomarkers & Prevention 29(7):1501-1508, 2020. e-Pub 2020. PMID: 32439797.
      55. Yang T, Wu C, Wei P, Pan W. Integrating DNA sequencing and transcriptomic data for association analyses of low-frequency variants and lipid traits. Human Molecular Genetics 29(3):515-526, 2020. e-Pub 2020. PMID: 31919517.
      56. Wu C, Pan W. A powerful fine-mapping method for transcriptome-wide association studies. Human Genetics 139(2):199-213, 2020. e-Pub 2020. PMID: 31844974.
      57. Yang T, Kim J, Wu C, Ma Y, Wei P, Pan W. An adaptive test for meta-analysis of rare variant association studies. Genetic Epidemiology 44(1):104-116, 2020. e-Pub 2020. PMID: 31830326.
      58. Wu C, Xu G, Shen X, Pan W. A regularization-based adaptive test for high-dimensional generalized linear models. Journal of Machine Learning Research 21:128, 2020. e-Pub 2020. PMID: 32802002.
      59. Wu C, Pan W. Integration of methylation QTL and enhancer-target gene maps with schizophrenia GWAS summary results identifies novel genes. Bioinformatics 35(19):3576-3583, 2019. e-Pub 2019. PMID: 30850848.
      60. Wu C, Xu G, Pan W. An adaptive test on high dimensional parameters in generalized linear models. Statistica Sinica 29(4):2163-2186, 2019. e-Pub 2019.
      61. Park JY, Wu C, Pan W. An adaptive gene-level association test for pedigree data. BMC Genetics 19(Suppl 1):68, 2018. e-Pub 2018. PMID: 30255770.
      62. Wu C, Pan W. Integration of enhancer-promoter interactions with GWAS summary results identifies novel schizophrenia-associated genes and pathways. Genetics 209(3):699-709, 2018. e-Pub 2018. PMID: 29728367.
      63. Wu C, Pan W. Integrating eQTL data with GWAS summary statistics in pathway based analysis. Genetic Epidemiology 42(3):303-316, 2018. e-Pub 2018. PMID: 29411426.
      64. Zhu L, Li Y, Chen YC, Carrera CA, Wu C, Fok A. Comparison between two post-dentin bond strength measurement methods. Scientific Reports 8(1):2350, 2018. e-Pub 2018. PMID: 29403067.
      65. Park JY, Wu C, Basu S, McGue M, Pan W. Adaptive SNP-Set Association Testing in Generalized Linear Mixed Models with Application to Family Studies. Behavior Genetics 48(1):55-66, 2018. e-Pub 2018. PMID: 29150721.
      66. Wu C, Park JY, Guan W, Pan W. An adaptive gene-based test for methylation data. BMC Proceedings 12(9):60, 2018. e-Pub 2018. PMID: 30275902.
      67. Xu Z, Wu C, Wei P, Pan W. A Powerful Framework for Integrating eQTL and GWAS Summary Data. Genetics 207(3):893-902, 2017. e-Pub 2017. PMID: 28893853.
      68. Xu Z, Wu C, Pan W, Neuroimaging Initiative AD. Imaging-wide association study: Integrating imaging endophenotypes in GWAS. Neuroimage 159:159-169, 2017. e-Pub 2017. PMID: 28736311.
      69. Liu B, Wu C, Shen X, Pan W. A novel and efficient algorithm for de novo discovery of mutated driver pathways. Annals of Applied Statistics 11(3):1481-1512, 2017. e-Pub 2017. PMID: 29479394.
      70. Wu C, Chen J, Kim J, Pan W. An adaptive association test for microbiome data. Genome Medicine 8(1):56, 2016. e-Pub 2016. PMID: 27198579.
      71. Wu C, Kwon S, Shen X, Pan W. A new algorithm and theory for penalized regression-based clustering. Journal of Machine Learning Research 17(188):1-25, 2016. e-Pub 2016. PMID: 31662706.
      72. Wu C, Demerath EW, Pankow JS, Bressler J, Fornage M, Grove ML, Chen W, Guan W. Imputation of missing covariate values in epigenome-wide analysis of DNA methylation data. Epigenetics 11(2):132-139, 2016. e-Pub 2016. PMID: 26890800.
      73. Bose M, Wu C, Pankow JS, Demerath EW, Bressler J, Fornage M, Grove ML, Mosley TH, Hicks C, North K, Kao WH, Zhang Y, Boerwinkle E, Guan W. Evaluation of microarray-based DNA methylation measurement using technical replicates: the Atherosclerosis Risk In Communities (ARIC) Study. BMC Bioinformatics 15(1):312, 2014. e-Pub 2014. PMID: 25239148.

      Review Articles

      1. Song M, Greenbaum J, Luttrell J 4th, Zhou W, Wu C, Shen H, Gong P, Zhang C, Deng HW. A review of integrative imputation for multi-omics datasets. Frontiers in Genetics 11:570255, 2020. e-Pub 2020. PMID: 33193667.

      Book Chapters

      1. Wu C. Using R for cell-type composition imputation in epigenome-wide association studies. In: Epigenome-Wide Association Studies. Springer Nature, 2022.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 09, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top